How does long COVID impact cognitive function?

Cognitive Domains Affected

Patients with long COVID frequently report impairments across multiple cognitive domains, often described as “brain fog.” Attention deficits and slowed processing speed are among the most common complaints, with up to 42% of previously hospitalized individuals demonstrating processing‐speed deficits on neuropsychological testing five months post‐discharge [1]. Episodic memory, particularly delayed verbal recall, is also disrupted in roughly one‐quarter of survivors [1], and executive dysfunction—including difficulties with planning, multitasking, and cognitive flexibility—has been documented in both subjective reports and objective tests [2][3]. Language disturbances, such as word‐finding difficulty, and visuospatial memory deficits have likewise been observed, though these are less consistently reported [3][4].

Prevalence and Risk Factors

Global estimates suggest that between 9% and 63% of SARS-CoV-2–infected individuals experience at least one persistent symptom three months after infection, with cognitive impairment among the top five most common manifestations [5]. In community and clinic‐based cohorts, 57% of long COVID patients report daily cognitive symptoms, compared to 27% of those without ongoing post-COVID condition [6]. Risk factors for long-term cognitive sequelae include female sex, older age, higher number of acute‐phase symptoms, and greater initial disease severity—particularly hospitalization or ARDS—though even those with mild acute illness can develop cognitive deficits [1][5][7][8]. Preexisting neurological or psychiatric disorders, lack of vaccination, and infection with pre-Omicron variants further elevate risk [5][7].

Subjective versus Objective Cognitive Assessment

While subjective complaints of brain fog, fatigue, and concentration lapses are widespread, objective neuropsychological testing reveals more nuanced deficits. In one outpatient cohort, most long COVID patients scored above clinical cutoffs on global cognition, yet individual‐level impairments were noted primarily in visual memory (23%) and attention (∼6%) [4]. Conversely, a large-scale systematic review confirmed persistent deficits in executive function, memory, attention, and processing speed up to one year post-infection [9]. Notably, subjective cognitive complaints correlate moderately with standardized measures such as the Stroop test, but fatigue appears to mediate much of the relationship between perceived and measured cognition [3].

Pathophysiological Mechanisms

Several, potentially overlapping, biological pathways have been implicated in long COVID cognitive dysfunction:

• Neuroinflammation and microglial activation: Elevated CNS cytokines and reactive microglia have been documented even after mild respiratory infection, leading to hippocampal neurogenesis impairment and oligodendrocyte loss [10].
• Microvascular injury: Endothelial dysfunction and microthrombi may disrupt cerebral perfusion, contributing to focal hypometabolism seen in subacute cases [11].
• Hypoxia‐related injury: Lower PaO₂/FiO₂ during acute illness correlates with worse memory outcomes, suggesting lasting effects of systemic hypoxia on vulnerable neural circuits [1].
• Autoimmunity and complement dysregulation: Dysregulated lectin‐pathway activity, particularly low mannan‐binding lectin levels, has been associated with brain fog onset, indicating a role for aberrant complement activation [12].
• RAS imbalance: Persistent renin–angiotensin system perturbations may promote neuroinflammation and BBB disruption, exacerbating cognitive dysfunction [13].
• Viral persistence: Although direct CNS infection remains controversial, residual viral particles could sustain low‐grade inflammation and immune activation [14][15].

Neuroimaging and Biomarkers

Structural and functional neuroimaging studies have reported regional gray‐matter reduction—especially in frontal and temporal lobes—and altered cerebral glucose metabolism. FDG‐PET scans in subacute inpatients showed frontal hypometabolism that tended to normalize by six months; however, some outpatients demonstrate cerebellar hypermetabolism correlated with executive and working memory deficits, possibly reflecting compensatory overactivity [4][16]. Serum and CSF biomarkers such as elevated neurofilament light chain, proinflammatory cytokines, and autoantibodies are under investigation as potential correlates of cognitive decline [11][17].

Impact on Daily Functioning

Persistent cognitive impairments hinder return to work, reduce full‐time employment likelihood, and worsen quality of life. In a survey of over 14 000 individuals, those with daily cognitive symptoms were less likely to maintain full‐time employment and exhibited higher rates of depression and functional impairment [6]. Qualitative interviews describe long COVID as a life-altering condition, characterized by anxiety, uncertainty, and dramatic disruptions in social and vocational trajectories [18].

Management and Future Directions

No disease-modifying treatments for long COVID cognitive symptoms currently exist. Symptom‐oriented approaches include cognitive rehabilitation, occupational therapy, graded exercise with caution for post-exertional malaise, and targeted pharmacotherapy for coexisting mood or sleep disorders [5][11][19]. Multidisciplinary post-COVID clinics are critical for individualized assessment and management [20]. Ongoing longitudinal and interventional studies aim to elucidate trajectories of cognitive recovery, identify reliable biomarkers, and test therapies—ranging from anti-inflammatories to neuromodulation—to prevent or mitigate long-term cognitive deficits. Continuous follow-up of diverse cohorts will be essential to determine whether cognitive impairments resolve, persist, or progress over time [21].